DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE | A202509 | PH HEALTH LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
GlaxoSmithKline LLC v. Banner Pharmacaps Inc. et al 3 patentsANDA 202530, 202509dutasteride | D. Del. | 2011-01-12 | Terminated 2013-08-26 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$2.05
per ea
Lowest NADAC/Unit
$2.05
per ea
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 10370028009DUTASTERIDE-TAMSULOSIN 0.5-0.4 | $2.05 | EA | Generic | — | 2026-06-17 |
| 10370028011DUTASTERIDE-TAMSULOSIN 0.5-0.4 | $2.05 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.